Clinical trials
Older Patients clinical trials
Below are recruiting older patients clinical trials, each written for real people, not researchers. We’re tracking 125 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06706661Recruiting
Nutrition support for older patients after hospital discharge
This trial tests whether offering nutritional help to older patients after they leave the hospital can improve their recovery. If you are at nutritional risk and can speak Danish or English, you may be able to join.
HerlevAges 50 years+ - NCT07586735Recruiting
A new preparative regimen for stem cell transplant in older patients with severe aplastic anemia
This study tests a new combination of drugs to prepare older patients (40–60 years old) with severe aplastic anemia for a stem cell transplant from a half-matched donor. The goal is to make the transplant safer and more effective for this age group.
Beijing, Beijing MunicipalityAges 40–60 - NCT06785740Recruiting
Statins for older stroke patients with frailty
This study looks at how well statins work in older stroke or TIA patients who are already taking them and also have some frailty. The goal is to understand if continuing statins is safe and helpful for this group.
Almere StadAges 70–120 - NCT06802991Recruiting
Optimized post-discharge care for older colon cancer patients
This trial tests better nutrition and follow-up care for older patients after colon cancer surgery. It focuses on people who are somewhat frail and at risk for poor nutrition, to see if extra support at home can improve recovery.
HerlevAges 65 years+ - NCT06828991RecruitingPhase 2
Mosunetuzumab for older DLBCL patients with residual ctDNA
This trial tests whether adding a targeted immunotherapy drug called mosunetuzumab after standard chemotherapy can help older adults with DLBCL who still have tiny traces of cancer DNA in their blood. If you qualify, the goal is to reduce the chance of the cancer coming back.
Rochester, New YorkAges 70 years+ - NCT06904690Recruiting
Health literacy training for older adults with type 2 diabetes
This trial tests whether an online training program can help older adults with type 2 diabetes better understand and use health information. It may improve your ability to manage your diabetes.
AnconaAges 60 years+ - NCT06934057RecruitingPhase 4
Cabozantinib and Nivolumab for older adults with kidney cancer
This trial is testing a combination of two drugs, cabozantinib and nivolumab, in people aged 70 or older who have advanced kidney cancer that hasn't been treated yet. The goal is to see if this combination works well and is safe for older patients.
AngersAges 70 years+ - NCT06938789Recruiting
Bleeding and confusion after hip fracture in older adults
This study looks at how bleeding after a hip fracture might affect confusion (delirium) in older adults. It will help doctors understand how to better manage bleeding to prevent confusion.
Aarhus, Central JutlandAges 75 years+ - NCT06984848Recruiting
Mouth spray for dry mouth in older adults
This trial tests an enzyme-containing mouth spray (Oral7®) to see if it helps with dry mouth, improves saliva flow, and boosts quality of life for older adults. If you often have a dry mouth, this spray might offer relief.
Kubang Kerian, KelantanAges 60 years+ - NCT07073703Recruiting
A personalized program for frailty in bladder or kidney cancer patients
This trial tests a personalized 6-month program to reduce frailty in older patients who are about to have surgery for bladder or kidney cancer. The program includes exercise and support, and aims to help patients stay stronger during and after treatment.
Saint-EtienneAges 65 years+ - NCT07090837Recruiting
Support study for caregivers of older adults
This study tests whether using a mobile app can help support caregivers of older adults receiving home-based care. It aims to see if this improves caregiver well-being.
SingaporeAges Any age - NCT07205354Recruiting
Food preference tool for older hospital patients
This study is creating a tool to better understand what foods older patients prefer, especially those with swallowing difficulties. It could help hospitals make meals more enjoyable and safer for you.
LyonAges 70 years+ - NCT07228624RecruitingPhase 2
Ruxolitinib before, during, and after transplant for myelofibrosis
This trial tests whether taking the drug ruxolitinib before, during, and after a stem cell transplant helps older patients with myelofibrosis or certain related blood disorders. The goal is to see if this approach can improve transplant success and reduce side effects.
Seattle, WashingtonAges 18–75 - NCT07309497Recruiting
Geriatric Assessment for Older Adults Before CAR-T or Bispecific Therapy
This trial studies how a simple geriatric assessment (a check-up for older adults) can help predict side effects and outcomes in patients aged 65+ who are about to receive CAR-T cell therapy or bispecific antibody treatment.
BernAges 65 years+ - NCT01137825Recruiting
Older patient cancer registry for a health check
This study is a registry that collects information from older adults who may be dealing with cancer. It includes a short health and function check to help doctors understand needs and guide care, even for people who turn out not to have cancer.
Boone, North CarolinaAges 65 years+ - NCT07444047Recruiting
MRI study of brain lesions in older MS patients
This study uses MRI scans to compare brain lesions in older patients with multiple sclerosis versus those with small vessel disease. It aims to improve how doctors tell apart these conditions and may lead to better treatment choices.
Oslo, OsloAges 50–80 - NCT07476859RecruitingPhase 4
Iron for heart attack recovery in older adults
This study tests whether giving iron through a vein can improve quality of life in older adults who recently had a heart attack or unstable angina and also have low iron levels. If you qualify, you would receive either iron or a placebo (inactive substance) to see if iron helps you feel better and recover faster.
El Palmar, MurciaAges 65 years+ - NCT07484932Recruiting
Tailored Treatment Dosing for Older Adults with Cancer
This trial tests a new dosing strategy (called TRTRM or ACTTOP) to find the right amount of cancer treatment for patients aged 65 and older. It aims to reduce side effects while keeping the treatment effective.
Hong KongAges 65 years+ - NCT07674498Recruiting
Immune health in older adults with advanced myeloma
This trial studies the immune system of adults 65 and older with multiple myeloma that has come back or not responded to treatment. It looks at how their immune fitness may affect their ability to receive newer therapies like CAR-T cells or bispecific antibodies.
Anderlecht, Brussels CapitalAges 65 years+ - NCT07501195Recruiting
Nutrition, Inflammation, Kidney Health in Older Hospital Patients
This study looks at nutrition, inflammation, kidney function, aging, body composition, and hydration in older patients who are hospitalized. It aims to understand how these factors affect recovery and health.
CopenhagenAges 65 years+ - NCT07530029Recruiting
Muscle loss in older patients with heart failure
This study looks at muscle loss (sarcopenia) in older patients (80+) hospitalized for heart failure with preserved pumping function. It may help doctors better understand how to care for this specific group.
Madrid, MadridAges 80 years+ - NCT06946537Recruiting
Nutrition and recovery in older hospital patients
This study looks at how nutrition and patient characteristics affect hospital stay, recovery, and survival in older adults. It aims to understand how a patient's nutritional status may influence their health outcomes during and after hospitalization.
CopenhagenAges 65 years+ - NCT07300995Recruiting
Pain coping skills for older women with breast cancer
This study tests a behavioral program to help older women with breast cancer learn skills to cope with pain. The program is done through video or phone sessions.
Durham, North CarolinaAges 55 years+ - NCT07369596Recruiting
Chemotherapy doses and survival in older lung cancer patients
This study looks at how lowering chemotherapy doses affects survival in older patients with advanced lung cancer who do not have certain genetic mutations. It may help doctors understand the best way to treat this group.
Hong KongAges 65 years+
Hear when a new Older Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for older patients?
- Yes. Clin2 currently lists 125 recruiting older patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a older patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a older patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.